Navigation Links
Drug regulatory officials giving the nod for sale of Unapproved drug formulations in India

In a recent court hearing over nimesulide, a controversial non-steroidal anti-inflammatory drug prescribed in India to treat // fever and pain the health ministry admitted that drug formulations unapproved by India’s drug regulatory agency and not evaluated for effectiveness are prescribed and sold across the country.

Social Jurist, a group of lawyers in New Delhi had filed a public interest lawsuit challenging the use of nimesulide among children. The group had also objected to unapproved combinations of nimesulide and other drugs, prescribed for use in adults, as illegal. The documents they submitted to the court indicated that dozens of unapproved formulations of nimesulide combined with various other drugs, such as analgesics, anti-allergy drugs, muscle relaxants, and other non-steroidal anti-inflammatory drugs, remain unapproved however are still available in the market.

The drugs controller general of India has however blamed the states’ drug regulatory officials for issuing manufacturing licences despite the absence of marketing approvals from the central health ministry. The drugs controller’s office has also stated that they have asked a panel of experts to examine whether nine of the fixed dose combinations suggested by the social Jurist are in fact available in the market.

Dr Reddys’s Laboratories one of India’s leading makers of nimesulide have announced that they have stopped making four combinations of nimesulide and explained its decision as part of rationalising its nimesulide strateg.
'"/>




Page: 1

Related medicine news :

1. Handbook cum diary on regulatory information
2. China tells officials not to hide SARS damage
3. FDA chief takes decision without two senior officials’ opinion
4. Pakistani health officials warned not to divulge dengue statistics
5. Fear Factor in Toronto: health officials fight Hepatitis A outbreak
6. Women who conceive after a year have a higher chance of giving birth prematurely
7. Women who conceive after a year have a higher chance of giving birth prematurely
8. Canada helps in giving birth to world first baby from frozen egg
9. Need for considering cardiovascular risks before giving HAART for HIV/aids patients
10. Help teenagers eat healthy by giving nutritional information along with food.
11. Holiday giving linked to altruistic nature of our ancestors
Post Your Comments:
(Date:3/21/2010)... are big winners in the comprehensive healthcare reform package that the House is expected to approve today, according to Congressman Chaka Fattah ... ... ... ... ...
(Date:3/18/2010)... ... events – it can actually take a toll on health, according to a new study ... ... impact the way people perceive negative events – it can actually take a toll on ...
(Date:3/18/2010)... , ... , ... ... WASHINGTON , March 18 Kids in Michigan will take center stage in the fight against tobacco on ...
(Date:3/18/2010)... State Leaders Urged to Support Higher Tobacco Taxes, Other Tobacco Prevention Initiatives , ... , , ... ... WASHINGTON , March 18 ...
(Date:3/18/2010)... Legacy(SM) , ... ... WASHINGTON , March 18 The ... , ...
Breaking Medicine News(10 mins):Health News:Rep. Fattah Says Small Businesses in Philadelphia Are Big Winners in Today's Healthcare Reform 2Health News:Rep. Fattah Says Small Businesses in Philadelphia Are Big Winners in Today's Healthcare Reform 3Health News:Low Self-Esteem Can Threaten Health, Online Dating Study Finds 2Health News:Low Self-Esteem Can Threaten Health, Online Dating Study Finds 3Health News:Michigan Kids 'Kick Butts' on March 24 2Health News:Michigan Kids 'Kick Butts' on March 24 3Health News:Michigan Kids 'Kick Butts' on March 24 4Health News:Michigan Kids 'Kick Butts' on March 24 5Health News:Missouri Kids 'Kick Butts' on March 24 2Health News:Missouri Kids 'Kick Butts' on March 24 3Health News:Missouri Kids 'Kick Butts' on March 24 4Health News:Missouri Kids 'Kick Butts' on March 24 5Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 2Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 3Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 4Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 5
... Hologic, Inc. (Nasdaq: HOLX ) today ... at the 8th Annual Needham Life Sciences Conference in ... p.m. (Eastern) and the Jefferies 3rd Annual Healthcare Conference ... 4:15 p.m. (Eastern).Interested parties are invited to listen to ...
... May 20 The National Osteoporosis Foundation (NOF) will ... Field; local D.C. celebrities and owners of FLEET FEET ... of EmpowHer, Michelle King Robson, at its Silver ... in Washington, D.C. Janet Hubert, entrepreneur and star of ...
... the accomplishments of medical education professionals in Texas. , ... ... national financial services group and the leading provider of retirement services ... it is soliciting statewide nominations for the 2009 TIAA-CREF Distinguished ...
... Years After Institute of Medicine Found Up To 98,000 Die ... the Institute of Medicine (IOM) sounded the alarm about the ... "To Err is Human." The report prompted a rush ... the decade since the report was published, little progress has ...
... CHARLOTTE, N.C., May 20 MedCath Corporation (Nasdaq: MDTH ) will host ... from its second quarter ended March 31, 2009. The company will issue a press ... Commission prior to the earnings call. , ... When: ...
... VSCP ), a leading provider of quantitative ... received notification from The NASDAQ Stock Market that it ... bid price requirement, and further, that it currently complies ... regain compliance with the bid price rule, the Company ...
Other Medicine News:Health News:Sally Field, Phil and Jan Fenty, and Michelle King Robson to Be Honored at Benefit for Osteoporosis and Bone Health Awareness 2Health News:Sally Field, Phil and Jan Fenty, and Michelle King Robson to Be Honored at Benefit for Osteoporosis and Bone Health Awareness 3Health News:Sally Field, Phil and Jan Fenty, and Michelle King Robson to Be Honored at Benefit for Osteoporosis and Bone Health Awareness 4Health News:Open Call for Nominations for the Sixth Annual TIAA-CREF Distinguished Medical Educator Award 2Health News:Open Call for Nominations for the Sixth Annual TIAA-CREF Distinguished Medical Educator Award 3Health News:Open Call for Nominations for the Sixth Annual TIAA-CREF Distinguished Medical Educator Award 4Health News:U.S. Health Care System Fails to Protect Patients From Deadly Medical Errors 2Health News:U.S. Health Care System Fails to Protect Patients From Deadly Medical Errors 3Health News:U.S. Health Care System Fails to Protect Patients From Deadly Medical Errors 4Health News:U.S. Health Care System Fails to Protect Patients From Deadly Medical Errors 5Health News:MedCath Corporation to Hold Conference Call on Second Quarter Results 2Health News:VirtualScopics Regains NASDAQ Compliance 2
(Date:3/17/2010)... international generic pharmaceuticals company, today announced that it has received approval from the U.S. Food & Drug Administration to market Alprazolam orally disintegrating tablets. Distribution of the product will ... ... ... ...
(Date:3/17/2010)... Md. , March 17 Micromet, Inc. (Nasdaq: MITI ) announced today the closing of its previously ... shares of common stock. As a result, Micromet sold a total of 11.5 million shares of its common stock at ... ... , , ...
(Date:3/17/2010)... 17 Med Gen Inc. (Pink Sheets: MDIN) today announced that ... the new direction of the company and its operations by providing up ... cash infusion of $100,000 in two separate payments of ... credit which the company can draw upon monthly. The credit line is ...
Breaking Medicine Technology:Actavis Receives Approval of Alprazolam ODT in the U.S. 2Actavis Receives Approval of Alprazolam ODT in the U.S. 3Micromet Closes $80.5 Million Public Offering of Common Stock 2Micromet Closes $80.5 Million Public Offering of Common Stock 3Micromet Closes $80.5 Million Public Offering of Common Stock 4Med Gen Inks Multi-Million Dollar Funding Deal 213 Bay Area Breast Cancer Survivors Showcased Fabulously in the New 2010 Pinups for Purpose Calendar 59842 113 Bay Area Breast Cancer Survivors Showcased Fabulously in the New 2010 Pinups for Purpose Calendar 59842 2CARE President to Speak at Inaugural Event of New Leadership Series on Women and Global Development 59840 1CARE President to Speak at Inaugural Event of New Leadership Series on Women and Global Development 59840 2CARE President to Speak at Inaugural Event of New Leadership Series on Women and Global Development 59840 3Actor Chris ODonnell to Receive 2009 Caritas Award 59838 1Actor Chris ODonnell to Receive 2009 Caritas Award 59838 2Actor Chris ODonnell to Receive 2009 Caritas Award 59838 3Actor Chris ODonnell to Receive 2009 Caritas Award 59838 4
... A. Grant, MD,Retina Macular Care, presented the ... that was designed to evaluate the adjuvant,use ... Lucentis(R),(ranibizumab) treatment of choroidal neovascularization secondary to,age-related ... presentation at,the 2008 Annual Meeting of the ...
... Italy, April 26 Bristol-Myers Squibb,Company (NYSE: ... E.A.R.L.Y. study,(ETV-079), in which treatment of antiviral-naive adult ... greater long-term viral,load reduction than adefovir at 96 ... Suppression of viral load to undetectable,levels is a ...
Other Medicine Technology:Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) 2Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) 3Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) 4BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients 2BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients 3BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients 4BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients 5BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients 6BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients 7
Inquire...
Inquire...
... In operation and optical performance, the SZX7 ... working comfort in every task, from routine ... one of the best zoom ratios in ... clarity, true color and accurate reproduction of ...
The Stereomicroscope Stemi 2000 meets your demands in two respects. On the one hand it offers the low-price advantage common with Greenough-type instruments, on the other hand it features superior pe...
Medicine Products: